2022 MVP Health Care Payment Policies (Section excerpts)
Customize your policy alerts
Sign up for all MVP Health Care policy alerts
Know when MVP Health Care releases new policies or updates existing guidance.
Monitor payer policy activity
This document governs MVP Health Care's 2022 reimbursement and billing policies (selected sections in this excerpt) and affects providers submitting claims to MVP for covered services. It includes rules for after-hours codes, allergy testing and serum preparation, and evaluation & management services, plus notification/prior authorization information.
No material clinical or coverage changes in this revision.
Coverage criteria and medical necessity rules
General coverage and specific code criteria
Covered when ALL of the following are met:
COVERAGE CRITERIA — E&M, consultation, observation, discharge, critical care, scope procedures and billing rules
Covered when ALL of the following billing rules and exclusions are satisfied:
Procedures that do not count toward critical care time
Split billing and Audiology coverage criteria
Split billing is permitted ONLY when ALL of the following conditions are met:
Audio-only, audiology timing, and supervised non-licensed behavioral health criteria
Audio-only, audiology timing, and supervised non-licensed behavioral health are covered when the listed conditions are met:
Contrast materials not separately reimbursable
Contrast materials are not separately reimbursable for the listed products when ALL of the following apply:
Non-licensed provider services — exclusion
Excluded — services performed by non-licensed providers are not reimbursable:
COVID-19 diagnostic and antibody testing coverage
COVID-19 diagnostic and antibody testing is covered when ALL of the following are met:
COVID-19 testing coverage criteria — applicable rules and limits
COVID-19 testing is covered ONLY when the following specific coverage criteria are satisfied:
Nutritional counseling and DSME coverage criteria
Nutritional counseling and Diabetes Self-Management Education (DSME) are reimbursable when ALL of the following are met:
ICD-10 diagnosis listing (informational)
Informational — ICD-10 diagnosis codes associated with nutritional counseling and diabetic management (no new coverage rules in this block):
Nutritional counseling & diabetic management coverage notes — reimbursable services and exclusions
Reimbursable services and exclusions — conditions for diabetic management and nutritional counseling:
Reimbursement guidance — reference to fee schedules/agreements
Reimbursement specifics are determined outside this policy:
Diagnosis-to-procedure matching requirement — claims must include appropriate diagnoses per LCD/NCD or society guidance
Diagnosis-to-procedure matching requirement — claims must meet the following:
Examples of procedure groups requiring diagnosis matching
- Transthoracic echocardiography codes (e.g., 93303-93304, 93306-93308, 93308, 93350-93352) require the correct diagnosis per the referenced LCD or claim will be denied.
- Facet joint injections, nerve conduction studies/EMG, corneal pachymetry, visual fields, herpes simplex antibody assays, vitamin D assays, ESR, and other listed laboratory/ophthalmology codes require correct diagnosis per the referenced LCD/NCD or clinical guidance or the claim will be denied.
Diagnosis-submission coverage requirements for listed laboratory tests
For the laboratory tests listed below, coverage requires submission of an appropriate diagnosis code consistent with the referenced guidance:
Diagnosis code lists by item (reference)
Reference lists of ICD-10 diagnosis codes by item (informational — use when validating diagnosis-to-procedure matching):
ESR diagnosis code list (reference)
ICD-10 diagnosis codes associated with ESR (informational reference):
Codes, code groups, and coding guidance
| 99050 | Service(s) provided in the office at times other than regularly scheduled office hours; must be billed with an E&M; not reimbursable when submitted with preventive visit codes. |
| 99051 | Regularly scheduled evening/weekend/holiday office hours; must be billed with an E&M; not separately reimbursed for Commercial and Medicare; Medicaid/HARP reimbursed at Medicaid rate. |
| 99053 | Services provided between 10:00 pm and 8:00 am at 24-hour facility; must be billed with an E&M; not reimbursed separately. |
| 99056 | Services typically provided in office but delivered out of office at patient request; must be billed with an E&M; not reimbursed separately. |
| 99058 | Services provided on an emergency basis in the office which disrupt scheduled services; must be billed with an E&M; not reimbursed separately. |
| 99060 | Service(s) provided on an emergency basis, out of the office, which disrupts other scheduled office services; must be billed with an E&M; considered inclusive to the E&M and not reimbursed separately. |
| 95165 | Supervision of preparation and provision of antigens for allergen immunotherapy; number of units/doses must be specified; first year/subsequent year unit limits apply. |
| 95004 | Allergen testing — number of tests must be specified; reimbursement limited to 80 units per calendar year. |
| 95024 | With allergenic extracts, immediate type reaction including interpretation and report; reimbursement limited to 40 units per calendar year. |
| 95027 | Allergen testing entry with number of tests specified; reimbursement limited to 40 units per calendar year. |
| 95028 | Intracutaneous (intradermal) tests with allergenic extracts, delayed type reaction, including reading; reimbursement limited to 30 units per calendar year. |
| 99201-99499 | Evaluation and Management codes; rules include denial of second inpatient E&M same day by same provider and urgent care exclusions when billed with well child/routine services. |
| 99050-99060 | After-hours E&M-related procedure codes; must be billed with an E&M; see After-Hours policy (99050 reimbursed unless submitted with preventive visit codes). |
| 99241-99245; 99251-99255 | Consultation codes — MVP follows CMS guidance and does not reimburse consultation codes. |
| 99218-99220; 99234-99236; 99217 | Hospital observation codes — only ordering provider may bill; codes are component/time-based per CPT guidelines. |
| 99221-99223; 99211-99215 | Initial hospital and outpatient visit codes — rules about AI modifier, one visit per provider per day, documentation and time/component requirements. |
| 99238-99239; 99217; 99234-99236 | Discharge service codes — timed/component-based; cannot bill discharge code and regular subsequent inpatient/observation code on same day. |
| 99291-99292 | Critical care E&M — minimum 30 minutes for 99291; incremental 99292 units for specified minute ranges. |
| (various non-GI scope families per Medicare RBRVS; see list) | Arthroscopic, endoscopic, and other non-GI scope procedure code families: highest RVU procedure reimbursed; secondary procedures reduced per Medicare multiple-procedure methodology (applies to listed families). |
| 99201-99499 | Evaluation and Management codes — audiologists may not bill these. |
| 69209 | Cerumen removal — audiologists may not bill; included in diagnostic test RVU. |
| 69210 | Cerumen removal — audiologists may not bill; included in diagnostic test RVU. |
| G0268 | Physician code for cerumen removal when physician performs removal same day as diagnostic test. |
| 92620 | Evaluation of central auditory function, with report; initial 60 minutes — timed code billed only if testing is ≥51% of the code's designated time. |
| 92621 | Evaluation of central auditory function, with report; each additional 15 minutes — additional timed units per CPT time rules. |
| 92626 | Evaluation of auditory rehabilitation status; first hour — timed code billed only if testing is ≥51% of the code's designated time. |
| 92627 | Evaluation of auditory rehabilitation status; each additional 15 minutes. |
| 92640 | Diagnostic analysis with programming of auditory brainstem implant, per hour. |
| 99441 | Telephone E/M service; 5-10 minutes. |
| 99442 | Telephone E/M service; 11-20 minutes. |
| 99443 | Telephone E/M service; 21-30 minutes. |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, per ml (considered inclusive to the primary procedure fee). |
| Q9951 | Low osmolar contrast material, 400+ mg/ml iodine concentration, per ml (not separately reimbursable). |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml (not separately reimbursable). |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml (not separately reimbursable). |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (not separately reimbursable). |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml (not separately reimbursable). |
| Q9959 | High osmolar contrast material code (listed as not separately reimbursable). |
| Applicable COVID-19 CPT/HCPCS codes per AMA and CMS | Applicable COVID-19 test CPT and HCPCS codes as published by AMA and CMS (providers should use current AMA/CMS code lists). |
| Z02.0 | Encounter for examination for admission to educational institution — will be denied as primary diagnosis for COVID-19 testing. |
| Z02.1; Z02.4; Z02.5; Z02.79; Z02.89 | Administrative/encounter examination codes (examples listed) that will be denied when submitted as primary diagnosis for COVID-19 testing — policy lists additional inappropriate codes. |
| 97802 | Medical nutritional therapy; initial assessment and intervention, individual, face-to-face, each 15 minutes. |
| 97803 | Medical nutritional therapy; re-assessment and intervention, individual, face-to-face, each 15 minutes. |
| 97804 | Medical nutritional therapy; group session. |
| G0270 | MDT related code listed as reimbursable. |
| G0271 | MDT related code listed as reimbursable. |
| E09.3293 | Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral. |
| E10.3211 | Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye. |
| E11.3213 | Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral. |
| E13.3293 | Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral. |
| E08.* | Diabetes mellitus due to underlying condition (multiple complication codes listed). |
| E09.* | Drug or chemical induced diabetes mellitus (multiple complication codes listed). |
| E10.* | Type 1 diabetes mellitus (selected complication codes listed). |
| E13.* | Other specified diabetes mellitus (multiple complication codes listed). |
| E09.43 | Drug or chemical induced Diabetes mellitus with neurological complications with diabetic autonomic (poly) neuropathy. |
| E09.44 | Drug or chemical induced Diabetes mellitus with neurological complications with diabetic amyotrophy. |
| E09.49 | Drug or chemical induced Diabetes mellitus with neurological complications with other diabetic neurological complication. |
| E10.3211 | Type 1 Diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye. |
| E10.3513 | Type 1 Diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral. |
| E10.37X1 | Type 1 Diabetes mellitus with diabetic macular edema, resolved following treatment, right eye. |
| E11.00 | Type 2 Diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC). |
| E11.3211 | Type 2 Diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye. |
| E11.621 | Type 2 Diabetes mellitus with foot ulcer. |
| E13.311 | Other specified Diabetes mellitus with unspecified diabetic retinopathy with macular edema. |
| O24.014 | Gestational/pre-existing diabetes in pregnancy (example O24 series entries). |
| 93303-93304 | Transthoracic echocardiography for congenital cardiac anomalies; Group 2. |
| 93306-93308 | Real time transthoracic echocardiography; Group 1. |
| 93308 | Echocardiography, transthoracic, real-time with image documentation (2D); Group 3. |
| 93350-93352 | Echocardiography during rest and cardiovascular stress test; Group 4. |
| 64490-64495 | Diagnostic or therapeutic agent injections with image guidance; cervical/thoracic/lumbar/sacral. |
| 64625; 64633-64636 | Destruction by neurolytic agent / facet radiofrequency neurotomy codes. |
| 76514 | Corneal pachymetry. |
| 92081-92083 | Visual field examination with interpretation and report. |
| 86695-86696 | Herpes Simplex virus antibody assays (type 1 and 2). |
| 82306 | Vitamin D 25 hydroxy test. |
| 82652 | Vitamin D 1,25 hydroxy test. |
| 85652 | Erythrocyte sedimentation rate; automated. |
| 82785; 86003; 86008 | Gammaglobulin IGE and allergen-specific IGE assays. |
| 82746 | Folic acid assay. |
| 82607 | Cyanocobalamin (Vitamin B12) assay. |
| 83001 | Gonadotropin Follicle Stimulating Hormone assay. |
| 82607 | Cyanocobalamin - Vitamin B12 (requires correct diagnosis per Novitas LCD or claim will be denied). |
| 83001 | Gonadotropin Follicle Stimulating Hormone (requires correct diagnosis per ASRM or claim will be denied). |
| 84481 | Assay of Triiodothyronine (T3) — refer to Appendix for appropriate diagnosis codes; correct diagnosis required or claim will be denied. |
| I4891 | Unspecified atrial fibrillation (listed in FSH appendix). |
| I959 | Hypotension, unspecified (listed in FSH appendix). |
| J449 | Chronic obstructive pulmonary disease, unspecified (listed in FSH appendix). |
| R051 | Acute cough (example HSV-related code listed in appendix). |
| R509 | Fever, unspecified (example HSV-related code listed in appendix). |
| B009 | Herpesviral infection, unspecified (example HSV-related code listed in appendix). |
| J301 | Allergic rhinitis due to pollen (listed in Gammaglobulin IGE appendix). |
| J449 | Chronic obstructive pulmonary disease, unspecified (listed in Gammaglobulin IGE appendix). |
| T7800XA | Anaphylactic reaction due to unspecified food, initial encounter (listed in Gammaglobulin IGE appendix). |
| C169 | Malignant neoplasm of stomach, unspecified (listed in ESR appendix). |
| C3411 | Malignant neoplasm of upper lobe, right bronchus or lung (listed in ESR appendix). |
| C8330 | Diffuse large B-cell lymphoma, unspecified site (listed in ESR appendix). |
| C8100 | Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site. |
| C8110 | Nodular sclerosis Hodgkin lymphoma, unspecified site. |
| C8330 | Diffuse large B-cell lymphoma, unspecified site. |
| C9000 | Multiple myeloma not having achieved remission. |
| D630 | Anemia in neoplastic disease. |
| D649 | Anemia, unspecified. |
| E1121 | Type 2 diabetes mellitus with diabetic nephropathy (listed among additional ICD-10 examples). |
| G35 | Multiple sclerosis (listed among additional ICD-10 examples). |
| H348130 | Central retinal vein occlusion, bilateral, with macular edema (listed among additional ICD-10 examples). |
Prior authorization, documentation and claim submission actions
Verify member eligibility and consult UM guides
Providers must check member eligibility and the Member Benefits Display and review MVP's Utilization Management Guides (and the Benefit Interpretation Manual) via mvphealthcare.com to determine whether prior authorization is required; payment policies are not a guarantee of payment.
Check member eligibility and UM guides before services
Providers must confirm Member eligibility, review the Member Benefits Display, and consult MVP's Utilization Management Guides (accessible via provider sign‑in at mvphealthcare.com) to determine prior authorization requirements; MVP payment policies do not guarantee payment.
Confirm eligibility and prior‑auth requirements
Providers are required to check member eligibility and the Member Benefits Display and consult MVP's Utilization Management Guides and the Benefit Interpretation Manual (sign‑in to mvphealthcare.com required) to determine if prior authorization is required; policy statements are not guarantees of payment.
Obtain authorization for In‑Office Only codes under split billing
Procedure codes listed on MVP's In‑Office Only list will not be reimbursed under a split‑billing arrangement unless an authorization is obtained; if authorized, reimbursement may be allowed for Medicare and Medicaid products.
Consult member and UM resources prior to billing
Providers must consult the Member Benefits Display, verify member eligibility, and review MVP's Utilization Management Guides and the Benefit Interpretation Manual (via provider account) to determine benefit coverage and prior authorization needs.
Obtain required prior authorization for select services
Obtain prior authorization for services identified in MVP's Utilization Management Guides; when an authorization is required it applies to all technical, professional, global and facility claims for the service.
Risk of administrative denial for missing prior approval
If services requiring prior authorization are provided without prior approval, MVP will apply administrative denial to all associated technical, professional, global and facility claims for those services.
Consult UM Guides and Benefit Interpretation Manual for clinical guidance
Providers should consult MVP's Utilization Management Guides and the Benefit Interpretation Manual for clinical guidelines and resources; access requires signing into mvphealthcare.com.
Verify eligibility and UM requirements before service
Providers must verify member eligibility, review the Member Benefits Display, and consult MVP's Utilization Management Guides (and Benefit Interpretation Manual) via their provider account to determine whether prior authorization is required; payment policies do not guarantee payment.
Participating providers must verify eligibility and prior‑auth needs
Participating providers must check member eligibility and the Member Benefits Display and consult MVP's Utilization Management Guides to determine if prior authorization is required; MVP payment policies are not a guarantee of payment.
Reference ICD‑10 codes for Nutritional Counseling
The policy provides ICD‑10 diagnosis codes associated with Nutritional Counseling and diabetic complications for provider reference when billing nutritional counseling/DSME services.
Bill G0108/G0109 per guidance and note Medicare MSA diagnosis limits
Codes G0108 (individual, per 30 minutes) and G0109 (group, per 30 minutes) are reimbursable for diabetes outpatient self‑management training; for Medicare MSA plans these codes are limited to specified diagnoses (other plans reimburse ICD‑10 in range E08–E09).
Refer to provider fee schedule or IPA agreement for reimbursement
For specific reimbursement amounts and payment methodology, providers must consult their provider fee schedule or IPA agreement.
Participating providers must verify eligibility and prior‑auth requirements
Participating providers must check member eligibility, review the Member Benefits Display, and consult MVP's Utilization Management Guides and Benefit Interpretation Manual to determine if prior authorization is required; MVP payment policies do not guarantee payment.
Submit diagnosis that matches applicable LCD/NCD or risk denial
Providers must submit the correct diagnosis with the claim in accordance with the applicable Medicare Local Coverage Determination (LCD) or National Coverage Determination (NCD); claims will be denied for lack of medical necessity if the diagnosis does not match.
Include correct diagnosis for B12 assay (82607) per Novitas LCD
For CPT 82607 (Cyanocobalamin/Vitamin B12), MVP requires the correct diagnosis to be submitted with the claim per the Novitas Solutions Inc. Local Coverage Determination; claims will be denied if the diagnosis criterion is not met.
Include correct diagnosis for FSH assay (83001) per ASRM guidance
For CPT 83001 (Gonadotropin FSH), MVP requires the correct diagnosis be submitted with the claim in accordance with the American Society for Reproductive Medicine; claims will be denied if clinical guidance is not met.
Submit appropriate diagnosis for thyroid testing per NCD/LCD
For thyroid panel tests (codes 84443, 84436, 84439, 84479), MVP requires the correct diagnosis be submitted with the claim in accordance with Medicare NCD/LCD guidance; claims will be denied if the diagnosis criterion is not met.
Include correct diagnosis for T3 assay (84481) or claim denied
For T3 assay (84481), MVP requires the correct diagnosis be submitted with the claim or the claim will be denied for lack of medical necessity; refer to the Appendix for appropriate diagnosis codes.
Use appendix ICD‑10 list for FSH billing reference
The appendix of the policy lists ICD‑10 diagnosis codes associated with Follicle Stimulating Hormone testing for provider billing reference.
Refer to appendix ICD‑10 codes for HSV testing
The policy appendix provides ICD‑10 diagnosis codes and descriptors for Herpes Simplex Virus‑related testing and encounters for provider reference.
Use appendix ICD‑10 codes for Gammaglobulin IGE testing
Refer to the Appendix for the list of ICD‑10 diagnosis codes and descriptors associated with Gammaglobulin IGE testing (allergy/immune diagnoses and adverse reaction codes).
Refer to appendix ICD‑10 codes for ESR testing
The policy appendix lists ICD‑10 diagnosis codes (primarily malignant neoplasms and lymphomas) that are associated with Erythrocyte Sedimentation Rate (ESR) testing for billing reference.
ESR diagnosis code reference (appendix)
See the policy Appendix and referenced CMS/LCD documents for an expanded ICD‑10 diagnosis code reference applicable to ESR claims and billing.
Defined terms used in this policy
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.